D. Satgé

发表

An ovarian dysgerminoma in Down syndrome. Hypothesis about the association.

A. Sasco, A. Chompret, M. Vekemans, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

An ovarian dysgerminoma in Down syndrome. Hypothesis about the association

A. Sasco, A. Chompret, M. Vekemans, 2004, International Journal of Gynecologic Cancer.

A history of miscarriages and mild prognathism as possible mode of presentation of mosaic trisomy 18 in women

D. Satgé, A. Geneix, J. Goburdhun, 1996, Clinical genetics.

An excess of testicular germ cell tumors in down's syndrome

A. Sasco, M. Vekemans, D. Satgé, 1997, Cancer.

Association of germ cell tumors and growth hormone treatment: a necessary clarification.

M. Nishi, D. Satgé, C. Rickert, 2011, The Journal of pediatrics.

Endometrial müllerian carcinosarcoma after cessation of tamoxifen therapy for breast cancer

A. Sasco, D. Satgé, J. Goburdhun, 1995, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Aspects of Digestive Tract Tumors in Down Syndrome: A Literature Review

A. Sasco, M. Vekemans, J. Fléjou, 2006, Digestive Diseases and Sciences.

Testicular cancer and intellectual disability

S. Culine, A. Sasco, M. Nishi, 2008 .

Breast cancer surveillance in women with intellectual disabilities

C. Kennedy, S. Sullivan, D. Willis, 2008 .

Age and stage at diagnosis: a hospital series of 11 women with intellectual disability and breast carcinoma

W. Jacot, D. Satgé, F. Raffi, 2014, BMC Cancer.

A tumor profile in Edwards syndrome (trisomy 18)

M. Nishi, M. Vekemans, N. Sirvent, 2016, American journal of medical genetics. Part C, Seminars in medical genetics.

[Thyroid microcarcinoma with a fatal outcome and 34 other unusually aggressive cases reported in the literature].

J. Grob, G. Methlin, D. Satgé, 1990, Archives d'anatomie et de cytologie pathologiques.

A case report of Down syndrome and centroblastic lymphoma.

M. Vekemans, J. Diebold, D. Satgé, 1996, Pathology, research and practice.

A fetus with Down syndrome and intratubular germ cell neoplasia.

G. Jacobsen, M. Vekemans, D. Satgé, 1996, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

A decreased incidence of neuroblastomas in Down's syndrome and overproduction of S-100 b protein.

D. Satgé, 1996, Medical hypotheses.

[Cardiac rhabdomyoma and apoptosis: are regression controlled by the body?].

D. Satgé, B. de Geeter, 1992, Archives des maladies du coeur et des vaisseaux.

An umbilical cord teratoma in a 17‐week‐old fetus

M. Chenard, D. Satgé, M. A. Laumond, 2001, Prenatal diagnosis.

Adenocarcinoma of the Lung in down Syndrome: First Clinical Report

J. Trédaniel, M. Rethoré, D. Satgé, 2013 .

Adenocarcinoma of the lung in Down syndrome: first clinical report.

J. Trédaniel, M. Rethoré, D. Satgé, 2013, Tumori.

Adolescent Girl with Down Syndrome and Lumbar Cutaneous Melanoma

B. de Fréminville, D. Satgé, W. Godard, 2014, Pediatric dermatology.

A survey of ocular tumors in Down syndrome alone or associated with another genetic affection

D. Lacombe, M. Vekemans, M. Rethoré, 2006 .

A tumor profile in Down syndrome.

M. Nishi, M. Vekemans, D. Satgé, 1998, American journal of medical genetics.

Aspects of the neoplasms observed in patients with constitutional autosomal trisomy.

H. van den Berghe, D. Satgé, H. V. D. Berghe, 1996, Cancer genetics and cytogenetics.

The epidemiology of neonatal tumours

A. Sasco, S. Moore, D. Satgé, 2003, Pediatric Surgery International.

Carcinogenesis in Down syndrome: what can be learned from trisomy 21?

D. Satgé, J. Bénard, 2008, Seminars in cancer biology.

The Pattern of Malignancies in Down Syndrome and Its Potential Context With the Immune System

D. Satgé, M. Seidel, 2018, Front. Immunol..

A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance Concept

D. Satgé, 2018, Front. Immunol..

Defining consensus norms for palliative care of people with intellectual disabilities in Europe, using Delphi methods: A White Paper from the European Association of Palliative Care

D. Oliver, L. Curfs, D. Satgé, 2015, Palliative medicine.

Are GATA1 mutations occurring at random in Down syndrome transient leukemia?

D. Satgé, 2014, Medical hypotheses.

The epidemiology of neonatal tumours. Report of an international working group.

A. Sasco, S. Moore, D. Satgé, 2003, Pediatric surgery international.

A tumor profile in Patau syndrome (trisomy 13)

M. Nishi, M. Vekemans, M. Chenard, 2017, American journal of medical genetics. Part A.

[Retroperitoneal teratomas in the perinatal period. Review of the literature concerning a neonatal, immature, aggressive teratoma].

M. Chenard, P. Lutz, D. Satgé, 1993, Annales de pediatrie.

[Gastric teratoma in newborn children].

G. Methlin, M. Chenard, D. Satgé, 1990, Annales de pediatrie.

A Third Case of Cardiac Neoplasm in a Fetus with Beckwith-Wiedemann Syndrome: Epicardial Angiofibroma

D. Satgé, B. de Geeter, François Desfarges, 2004, Fetal Diagnosis and Therapy.

A critical re-examination of the role of chromosome translocations in cancer

D. Satgé, 2017 .

Analysis of Somatic Mutations in Cancer Tissues Challenges the Somatic Mutation Theory of Cancer

D. Satgé, 2013 .

Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature.

S. Moore, C. Stiller, K. Pritchard-Jones, 2003, Cancer genetics and cytogenetics.

A 22-year French Experience with Solid Tumors in Children with Down Syndrome

A. Sasco, A. Chompret, D. Lacombe, 2003, Pediatric hematology and oncology.

A lack of neuroblastoma in Down syndrome: a study from 11 European countries.

W. Kamps, A. Sasco, F. Langmark, 1998, Cancer research.

Age and stage at diagnosis: a hospital series of 11 women with intellectual disability and breast carcinoma

W. Jacot, D. Satgé, F. Raffi, 2014, BMC Cancer.

Cancer diagnoses among older people with intellectual disability compared with the general population: a national register study.

B. Trétarre, A. Axmon, G. Ahlström, 2020, Journal of intellectual disability research : JIDR.

Cancer screening in adults with down syndrome, a proposal.

M. Rethoré, D. Satgé, J. Rouëssé, 2020, European journal of medical genetics.

Colorectal Cancer in People with Intellectual Disabilities

D. Willis, D. Satgé, E. Samalin, 2018, Oncology.

Breast cancer and screening in persons with an intellectual disability living in institutions in France

B. Trétarre, W. Jacot, F. Bessaoud, 2017, Journal of intellectual disability research : JIDR.

Age at breast cancer screening in women with intellectual disability

M. Nishi, D. Satgé, 2022, Journal of medical screening.

Melanoma and intellectual disability: do prognostic factors at diagnosis differ from general population?

B. Trétarre, B. Guillot, F. Bessaoud, 2022, Journal of intellectual disability research : JIDR.

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

J. Trédaniel, M. Nishi, Jean Trédaniel, 2016, Lung cancer international.

A 23‐year‐old woman with down syndrome, type 1 neurofibromatosis, and breast carcinoma

A. Sasco, D. Goldgar, M. Vekemans, 2004, American journal of medical genetics. Part A.

Breast screening guidelines should be adapted in Down's syndrome

A. Sasco, D. Satgé, 2002, BMJ : British Medical Journal.

A mucoepidermoid carcinoma in a young man with intellectual disability: review of oral cancer in people with intellectual disability.

S. Culine, M. Nishi, M. Hennequin, 2013, Oral surgery, oral medicine, oral pathology and oral radiology.

A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries

C. Stiller, Ó. Zurriaga, M. Nishi, 2013, Journal of Neuro-Oncology.

Down syndrome patients are less likely to develop some (but not all) malignant solid tumours

M. Vekemans, D. Satgé, 2011, Clinical genetics.

Overcoming challenges in diagnosing and treating cancers in people with intellectual disability: a case analysis

S. Bhaumik, Arshya Vahabzadeh, D. Satgé, 2014 .

[Breast cancer in women with trisomy 21].

A. Sasco, M. Rethoré, D. Satgé, 2001, Bulletin de l'Academie nationale de medecine.

Are solid tumours different in children with Down's syndrome?

A. Sasco, B. Lacour, D. Satgé, 2003, International journal of cancer.

A Low-Grade Follicular Thyroid Carcinoma in a Woman with down Syndrome

A. Sasco, M. Vekemans, C. Mircher, 2004, Tumori.

Neuropathological review of 138 cases genetically tested for X-linked hydrocephalus: evidence for closely related clinical entities of unknown molecular bases

N. Drouot, C. Fallet-Bianco, P. Gressens, 2013, Acta Neuropathologica.

Neonatal neuroblastoma and in utero exposure to progestagens

A. Sasco, J. Soulier, D. Satgé, 1998 .

Hepatic calcifications in a fetus with trisomy 9 that underwent cordocentesis

C. Stoll, B. Gasser, D. Satgé, 1994, Prenatal diagnosis.

[Complete and homogenous trisomy 9 detected in utero].

D. Satgé, A. Geneix, P. Malet, 1992, Journal de gynecologie, obstetrique et biologie de la reproduction.

Ulcerative terminal ileitis after BCG therapy for bladder carcinoma

I. Pommepuy, J. Fléjou, D. Satgé, 2002, Histopathology.

Cancer mortality in Down syndrome in California

N. Voirin, A. Sasco, S. Day, 2008 .

[Fatal mesenteric ischemic accident caused by mesenteric inflammatory veno-occlusive disease].

J. Fléjou, D. Satgé, J. Goburdhun, 1999, Annales de pathologie.

Angioinvasive plasma cell granulomas of the lung

D. Satgé, N. Roeslin, A. Warter, 1987, Cancer.

Antenatal exposure to atenolol and retroperitoneal fibromatosis.

A. Sasco, P. Lemonnier, J. Hemet, 1997, Reproductive toxicology.

A Medical Enigma: Persons with Down Syndrome Do Not Develop Medulloblastoma

D. Satgé, C. Rickert, 2008, Neuroepidemiology.

Another reason to look for tumor suppressor genes on chromosome 21

A. Sasco, D. Satgé, A. Geneix, 1998, Genes, chromosomes & cancer.

Antenatal therapeutic drug exposure and fetal/neonatal tumours: review of 89 cases.

J. Little, A. Sasco, D. Satgé, 1998, Paediatric and perinatal epidemiology.

Identification of novel L1CAM mutations using fluorescence‐assisted mismatch analysis

A. Munnich, N. Philip, N. Le Meur, 1998, Human mutation.

Association Down Syndrome-Retinoblatoma: A New Observation

J. Beckmann, D. Schorderet, F. Munier, 2005, Ophthalmic genetics.

Maternal serum s100b protein is ineffective for Down syndrome screening

J. Oury, S. Uzan, D. Satgé, 1999, Prenatal diagnosis.

Aspects of intracranial and spinal tumors in patients with Down syndrome and report of a rapidly progressing Grade 2 astrocytoma

A. Sasco, H. Ohgaki, M. Vekemans, 2001, Cancer.

Nervous system: Peripheral neuroblastic tumours (Neuroblastoma, Ganglioneuroblastoma, Ganglioneuroma)

J. Couturier, D. Satgé, 2011 .

A review of malignancies in fragile X syndrome and report of an Ewing sarcoma

B. Bui, D. Lacombe, M. Vekemans, 2008 .

Cytogenetic anomalies in neonatal and fetal solid tumors

D. Satgé, 1989 .

A Lower Risk of Dying from Urological Cancer in Down Syndrome: Clue for Cancer Protecting Genes on Chromosome 21

S. Culine, A. Sasco, D. Satgé, 2009, Urologia Internationalis.

Down's syndrome protects against breast cancer: Is a constitutional cell microenvironment the key?

D. Satgé, N. Béron-Gaillard, J. Bénard, 2005, International journal of cancer.

Awareness on oral cancer in people with intellectual disability.

S. Culine, M. Nishi, M. Hennequin, 2012, Oral Oncology.

[Neonatal carcinoma. Review of the literature apropos of a case].

P. Lutz, D. Satgé, J. Levy, 1988, Bulletin du cancer.

Awareness of eye tumours in Down syndrome.

F. Munier, D. Satgé, 2009, The British journal of ophthalmology.

Assessing cancer in people with profound and multiple disabilities

M. Nishi, B. Trétarre, D. Satgé, 2023, BMC Cancer.

An infant with Down syndrome and retinoblastoma A possible non-fortuitous association

A. Sasco, L. Desjardins, M. Vekemans, 2001, Ophthalmic Genetics.

[Valvular cyst and atrioventricular canal in a child with trisomy 21].

L. Camilleri, M. Chenard, D. Satgé, 1994, Annales de pathologie.